Selected article for: "ambient air and normal range"
Author: Cao, Wei; Liu, Xiaosheng; Bai, Tao; Fan, Hongwei; Hong, Ke; Song, Hui; Han, Yang; Lin, Ling; Ruan, Lianguo; Li, Taisheng
Title: High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
  • Document date: 2020_3_21
    • ID: u3gmpklc_7
    Snippet: The diagnosis was modified to COVID-19, severe type. Highdose IVIg was started on January 28 (hospital day 7) at 25 g/d for 5 days (body weight 66 kg). Moxifloxacin was continued until February 2. On the same day after IVIg infusion, the patient became afebrile. No adverse event was reported. Over the next few days, his clinical status gradually improved. The supplemental oxygen was discontinued, and his oxygen saturation level returned to 97%-98.....
    Document: The diagnosis was modified to COVID-19, severe type. Highdose IVIg was started on January 28 (hospital day 7) at 25 g/d for 5 days (body weight 66 kg). Moxifloxacin was continued until February 2. On the same day after IVIg infusion, the patient became afebrile. No adverse event was reported. Over the next few days, his clinical status gradually improved. The supplemental oxygen was discontinued, and his oxygen saturation level returned to 97%-98% on February 3 when breathing ambient air. Test results on February 5 showed recovered lymphocyte count to 1.6 ×10 9 /L. The ESR decreased to 31 mm/h, and hsCRP returned to normal range. The CT scan showed partial resolution of previous lesions ( Figure 1A ). Two consecutive oropharyngeal swabs on February 2 and 3 were both negative for 2019-nCoV. The patient was discharged on February 5.

    Search related documents:
    Co phrase search for related documents
    • adverse event and body weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • adverse event and clinical status: 1, 2, 3, 4, 5, 6, 7
    • adverse event and CT scan: 1, 2, 3, 4, 5, 6
    • adverse event and hospital day: 1, 2, 3, 4, 5
    • adverse event and IVIg infusion: 1
    • adverse event and lymphocyte count: 1, 2
    • adverse event and normal range: 1, 2, 3
    • adverse event and oropharyngeal swab: 1
    • ambient air and body weight: 1, 2, 3, 4
    • ambient air and clinical status: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • ambient air and CT scan: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • ambient air and hospital day: 1, 2, 3, 4, 5
    • ambient air and lymphocyte count: 1, 2, 3, 4, 5
    • ambient air and normal range: 1, 2
    • ambient air and oropharyngeal swab: 1
    • body weight and clinical status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • body weight and hospital day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • body weight and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • body weight and normal range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12